Today the Ending the Epidemic Task Force, convened by the New York State Department of Health (DOH) at the behest of Governor Andrew M. Cuomo, completed its comprehensive, rigorous, and unprecedented Plan to End AIDS in New York State by 2020.
TAG’s annual review of progress we’ve made on the the fight to end HIV/AIDS, Viral Hepatitis, and Tuberculosis.
November 2014 Examples of media coverage: Primer Paciente “Curado” del VIH por un Trasplante de Sangre de Cordón Umbilical – El Mundo, November 6, 2014 Doctors “Cure” HIV Patient with Blood Transplant – Local: Spain’s News in English, November 6,…
November 2014 Examples of media coverage: French Scientists Find Mechanism for Spontaneous HIV Cure – Agence France-Presse, November 4, 2014 Scientists See Mechanism for Spontaneous HIV “Cure” (Update) – Agence France-Presse, November 4, 2014 HIV: Genetic Mutation Leads to Two Men…
Letter from TAG and others asking for withdrawal of mandatory quarantine requirement for entering the US through Newark and JFK airports who have had direct contact with individuals with Ebola Virus Disease in Guinea, Liberia, and Sierra Leone.
Letter from TAG and other advocates expressing concerns about proposed Medicaid criteria that will limit access to sofosbuvir and other lifesaving hepatitis C medications.
Treatment Action Group (TAG) welcomes today’s announcement by the New York State Department of Health (DOH) of the Ending the Epidemic Task Force to more fully develop Governor Andrew Cuomo’s Plan to End AIDS as an epidemic in New York State by the year 2020.
Letter asking to speak to key staff at Novartis to discuss its support of the clinical research required to more fully understand the efficacy of Menveo in adolescents and adults living with HIV.
Generic drug registration, licensing, and a trip to Gilead’s islands Karyn Kaplan and Tracy Swan Access to essential medicines is part of the human right to health. The HIV/AIDS epidemic has demonstrated that generic competition is key to massive antiretroviral…
The basics of generic medications, bioequivalence, and the push for good manufacturing practices Tim Horn Securing access to generic drugs to treat HIV, hepatitis C virus (HCV), and tuberculosis (TB) is now one of the most prominent strategies of global…